Amanote Research
Register
Sign In
PMS5 Data Visualization of Treatment Patterns of Medicare Psoriatic Arthritis Patients Who Initiate Tumor Necrosis Factor Therapy
Value in Health
- United Kingdom
doi 10.1016/j.jval.2012.03.194
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
June 1, 2012
Authors
O. Baser
L. Wang
L. Xie
H. Yuce
Publisher
Elsevier BV
Related search
PMS73 Visualizing Treatment Patterns of Veteran Patients With Rheumatoid Arthritis Who Initiated Tumor Necrosis Factor Therapy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
PMS9 Biologic Therapy Patterns and Associated Costs in Rheumatoid Arthritis Patients Who Initiated a Tumor Necrosis Factor Antagonist Over Two Years
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Erratum To: Anti-Tumor Necrosis Factor-Α Therapy and Changes of Flow-Mediated Vasodilatation in Psoriatic and Rheumatoid Arthritis Patients
Internal and Emergency Medicine
Internal Medicine
Emergency Medicine
Effectiveness and Safety of Adalimumab in Patients With Ankylosing Spondylitis or Psoriatic Arthritis and History of Anti-Tumor Necrosis Factor Therapy
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
Psoriatic Skin Lesions Induced by Tumor-Necrosis-Factor-Alpha-Therapy
Case Reports in Clinical Medicine
Anti-Tumor Necrosis Factor (TNF) Drugs for the Treatment of Psoriatic Arthritis: An Indirect Comparison Meta-Analysis
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Value of Antidrug Antibody Screening in Moderate-To-Severe Rheumatiod Arthritis Patients Who Failed Initial Tumor Necrosis Factor-Alpha Treatment
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Tumor Necrosis Factor Α Antagonists in the Treatment of the Patients With Rheumatoid Arthritis
Reumatologia
Rheumatology
Allergy
Immunology
Predictors of Treatment Initiation With Tumor Necrosis Factor-Α Inhibitors in Patients With Rheumatoid Arthritis
Journal of Managed Care Pharmacy
